XML 91 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 19 - Reportable Segments (Tables)
3 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
 
Display
Technologies
 
Optical
Communications
 
Environmental
Technologies
 
Specialty
Materials
 
Life
Sciences
 
All
Other
 
Total
Three months ended
  March 31, 2014
                                       
 
Net sales
$
929 
 
$
593 
 
$
275 
 
$
261 
 
$
210 
 
$
21 
 
$
2,289 
 
Depreciation (1)
$
173 
 
$
36 
 
$
30 
 
$
27 
 
$
15 
 
$
 
$
286 
 
Amortization of purchased intangibles
     
$
             
$
       
$
 
Research, development and engineering expenses (2)
$
45 
 
$
37 
 
$
21 
 
$
33 
 
$
 
$
28 
 
$
169 
 
Restructuring, impairment and other charges
$
 
$
12 
                         
$
17 
 
Equity in earnings of affiliated companies
$
(9)
       
$
             
$
 
$
(6)
 
Income tax (provision) benefit
$
(198)
 
$
(19)
 
$
(21)
 
$
(16)
 
$
(8)
 
$
16 
 
$
(246)
 
Net income (loss) (3)
$
209 
 
$
27 
 
$
43 
 
$
31 
 
$
17 
 
$
(40)
 
$
287 
                                         
Three months ended
  March 31, 2013
                                       
 
Net sales
$
650 
 
$
470 
 
$
228 
 
$
258 
 
$
207 
 
$
 
$
1,814 
 
Depreciation (1)
$
124 
 
$
34 
 
$
31 
 
$
39 
 
$
14 
 
$
 
$
246 
 
Amortization of purchased intangibles
     
$
             
$
       
$
 
Research, development and engineering expenses (2)
$
19 
 
$
35 
 
$
23 
 
$
35 
 
$
 
$
36 
 
$
153 
 
Equity in earnings of affiliated companies
$
133 
 
$
                   
$
 
$
139 
 
Income tax (provision) benefit 
$
(80)
 
$
(17)
 
$
(13)
 
$
(19)
 
$
(5)
 
$
15 
 
$
(119)
 
Net income (loss) (3)
$
349 
 
$
35 
 
$
27 
 
$
39 
 
$
12 
 
$
(28)
 
$
434 
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
 
Three months ended
March 31,
 
2014
 
2013
Net income of reportable segments
$
327 
 
$
462 
Non-reportable segments
 
(40)
   
(28)
Unallocated amounts:
         
Net financing costs (1)
 
(29)
   
(34)
Stock-based compensation expense
 
(15)
   
(11)
Exploratory research
 
(27)
   
(24)
Corporate contributions
 
(5)
   
(13)
Equity in earnings of affiliated companies, net of impairments (2)
 
92 
   
34 
Asbestos settlement
 
(2)
   
(2)
Purchased collars and average forward contracts
 
   
24 
Other corporate items (3)
 
(2)
   
86 
Net income
$
301 
 
$
494